文献速递鼻科

射频消融对比激光神经松解术治疗慢性鼻炎

Radiofrequency Ablation Versus Laser Neurolysis of the Posterior Nasal Nerve in Patients With Chronic Rhinitis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2026-02-06

回顾性队列研究比较单纯鼻后神经射频消融(RAPN)与联合CO₂激光鼻后神经松解(RPN3)治疗药物难治性慢性鼻炎的疗效。共分析101例患者(RPN3组76例,RAPN组25例),两组在1、3、6个月均显著改善症状,但RPN3组在1至6个月改善更优,尤其在流涕和鼻痒方面。

要点

  • RAPN与RPN3均能有效改善药物难治性慢性鼻炎症状。
  • RPN3在流涕和鼻痒症状改善上优于单纯RAPN。
  • 两组rTNSS应答率分别达91%-100%(RPN3)和84%-96%(RAPN)。

核心结论

  • RAPN与RPN3均对药物难治性慢性鼻炎有效,联合CO₂激光神经松解可提供更优症状缓解。

研究设计与样本

  • 回顾性队列研究,单中心三级医疗中心,纳入2023年2月至2024年5月接受RAPN或RPN3的成人患者共101例(RPN3组76例,RAPN组25例)。

主要发现

  • 两组基线rTNSS和NOSE评分无显著差异(P=.144和.414)。
  • 两组在1、3、6个月随访时rTNSS和NOSE评分均显著改善(P<.001)。
  • RPN3组在1至6个月改善程度显著优于RAPN组(P=.039-.045),尤其在流涕和鼻痒子评分上(P=.003-.039)。
  • rTNSS应答率RPN3组为91%-100%,RAPN组为84%-96%。

关键数值与推荐

  • 纳入标准:24小时回顾性鼻部症状总分(rTNSS)≥3,流涕评分≥1,NOSE评分≥11。
  • 排除标准:慢性鼻窦炎、鼻息肉、凝血功能障碍。
  • 主要终点:治疗后1、3、6个月rTNSS、NOSE评分变化及应答率(较基线改善≥30%)。

临床怎么用

  • 对于药物难治性慢性鼻炎患者,可考虑RAPN或RPN3,联合CO₂激光神经松解可能更有利于改善流涕和鼻痒。

局限性

  • 回顾性研究设计,样本量较小且分组不均衡(RPN3组76例 vs RAPN组25例),单中心结果可能需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the clinical outcomes of radiofrequency ablation of the intraturbinate segment of the posterior nasal nerve (RAPN) alone versus combined RAPN with CO₂ laser posterior nasal nerve neurolysis (RPN3) in patients with chronic rhinitis refractory to medical therapy. STUDY DESIGN: Retrospective cohort study. SETTING: Single tertiary care center. METHODS: Adult patients with chronic rhinitis unresponsive to medical treatment for over 6 months who underwent either RAPN or RPN3 between February 2023 and May 2024 were included. Inclusion criteria were 24-hour reflective total nasal symptom score (rTNSS) ≥ 3, rhinorrhea score ≥1, and NOSE score ≥11. Exclusion criteria included chronic rhinosinusitis, nasal polyps, and coagulopathy. Demographics and comorbidities were documented. Primary endpoints were changes in rTNSS, NOSE scores, and response rate (≥30% improvement from baseline) at 1-, 3-, and 6-months posttreatment. RESULTS: A total of 101 patients were analyzed (RPN3: 76; RAPN: 25). Baseline rTNSS and NOSE scores were comparable between the two groups (P = .144 and .414, respectively). Both groups demonstrated significant improvements in rTNSS and NOSE scores at all follow-up points (P < .001). From 1 to 6 months, RPN3 achieved significantly greater improvements compared to RAPN (P = .039-.045), particularly in the rhinorrhea and nasal itching sub-scores (P = .003-.039). Response rates for rTNSS ranged from 91% to 100% in the RPN3 group and 84% to 96% in the RAPN group. CONCLUSION: Both RAPN and RPN3 are effective in treating chronic rhinitis unresponsive to medication. The addition of CO₂ laser posterior nasal nerve neurolysis (RPN3) provides superior symptomatic relief, particularly for rhinorrhea and nasal itching.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Lin CC, Hwang YL, Liao JY, et al. Radiofrequency Ablation Versus Laser Neurolysis of the Posterior Nasal Nerve in Patients With Chronic Rhinitis. Otolaryngol Head Neck Surg. 2026. PMID: 41649252. doi:10.1002/ohn.70156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。